Actual incidence of cerebral infarction after thoracic endovascular aortic repair: a magnetic resonance imaging study.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
18 01 2022
Historique:
received: 24 02 2021
revised: 03 08 2021
accepted: 04 08 2021
pubmed: 12 10 2021
medline: 8 3 2022
entrez: 11 10 2021
Statut: ppublish

Résumé

The actual incidence of cerebral infarction (CI), including asymptomatic infarction, owing to thoracic endovascular aortic repair (TEVAR) has not been reported in detail. This study was performed to investigate the incidence of post-TEVAR CI by using diffusion-weighted magnetic resonance imaging (DW-MRI) and to determine the risk factors for both symptomatic and asymptomatic CI. We examined 64 patients undergoing TEVAR at our institute between April 2017 and November 2020. Aortic atheroma was graded from 1 to 5 by preoperative computed tomography. Cerebral DW-MRIs were conducted 2 days after the procedure to diagnose postoperative CI. A total of 44 new foci were detected by post-interventional cerebral DW-MRI in 22 patients (34.4%). Only one patient developed a symptomatic stroke (1.6%), and TEVAR was successfully completed in all cases. Debranching of the aortic arch and left subclavian artery occlusion with a vascular plug was performed in 19 (29.7%) and 12 (18.8%) patients, respectively. The number of patients with proximal landing zones 0-2 was significantly higher in the CI group than in the non-CI group (68.2% vs 11.9%; P < 0.001). The following risk factors were identified for asymptomatic CI: aortic arch debranching (P < 0.001), left subclavian artery occlusion (P = 0.001) and grade 4/5 aortic arch atheroma (P = 0.048). Over one-third of the patients examined by cerebral DW-MRI after TEVAR were diagnosed with CI. High-grade atheroma and TEVAR landing in zone 0-2 were found to be positively associated with asymptomatic CI. 02-014.

Identifiants

pubmed: 34632503
pii: 6386715
doi: 10.1093/icvts/ivab240
pmc: PMC8766213
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-273

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Références

J Vasc Surg. 2018 Dec;68(6):1656-1666
pubmed: 29804744
Catheter Cardiovasc Interv. 2000 Apr;49(4):389-94
pubmed: 10751762
Eur J Vasc Endovasc Surg. 2012 Mar;43(3):269-75
pubmed: 22240331
Br J Surg. 2015 Feb;102(3):194-201
pubmed: 25511816
Ann Surg. 2014 Oct;260(4):691-6; discussion 696-7
pubmed: 25203886
Lancet Neurol. 2007 Jul;6(7):611-9
pubmed: 17582361
J Endovasc Ther. 2019 Feb;26(1):76-80
pubmed: 30569808
J Endovasc Ther. 2007 Aug;14(4):568-73
pubmed: 17696634
J Endovasc Ther. 2016 Apr;23(2):393-5
pubmed: 26896417
Interact Cardiovasc Thorac Surg. 2016 Sep;23(3):469-76
pubmed: 27241049
Eur J Vasc Endovasc Surg. 2020 Jul;60(1):57-66
pubmed: 31883685
Ann Vasc Surg. 2020 Nov;69:17-26
pubmed: 32505683
J Endovasc Ther. 2004 Dec;11 Suppl 2:II62-71
pubmed: 15760265
Eur Heart J. 2005 Jul;26(13):1269-75
pubmed: 15716287
Ann Thorac Surg. 2007 Oct;84(4):1195-200; discussion 1200
pubmed: 17888969
Ann Thorac Surg. 2009 Aug;88(2):498-504
pubmed: 19632400
J Thorac Cardiovasc Surg. 2012 May;143(5):1007-13
pubmed: 21783209
Interact Cardiovasc Thorac Surg. 2021 May 10;32(5):764-772
pubmed: 33575743
Ann Vasc Surg. 2019 Nov;61:310-316
pubmed: 31381997
Ann Thorac Surg. 2011 Jul;92(1):97-102; discussion 102-3
pubmed: 21718834
Ann Thorac Surg. 2014 Jul;98(1):53-8
pubmed: 24841546
Eur J Vasc Endovasc Surg. 2021 Feb;61(2):239-245
pubmed: 33358103
N Engl J Med. 2003 Mar 27;348(13):1215-22
pubmed: 12660385
Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1071-1078
pubmed: 30629169
Ann Vasc Surg. 2016 Oct;36:132-138
pubmed: 27401834
Br J Surg. 2018 Mar;105(4):366-378
pubmed: 29431856
Eur J Vasc Endovasc Surg. 2017 Feb;53(2):176-184
pubmed: 27993454

Auteurs

Sohsyu Kotani (S)

Department of Cardiovascular Surgery, Tokai University School of Medicine, Kanagawa, Japan.

Yoshito Inoue (Y)

Department of Cardiovascular Surgery, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.

Naohiko Oki (N)

Department of Cardiovascular Surgery, Hiratsuka City Hospital, Kanagawa, Japan.

Hideki Yashiro (H)

Department of Radiology, Hiratsuka City Hospital, Kanagawa, Japan.

Takashi Hachiya (T)

Department of Cardiovascular Surgery, Saiseikai Yokohamashi Tobu Hospital, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH